Upload
jocelin-clarke
View
218
Download
0
Tags:
Embed Size (px)
Citation preview
What are we talking about?
Functional gastrointestinal disorders (FGIDs) are defined as a variable combination of chronic or recurrent gastrointestinal symptoms not explained by structural or biochemical abnormalities.
…..We should focus on identifying ‘‘key’’ features or symptoms that characterize functional pain, and promote a
positive diagnosis rather than a diagnosis of exclusion.
….indeed, the criteria were designed to be used as diagnostic tools
What are we talking about?
243 children (4-18 yr-old): 122 Pain Predominant-FGID
All underwent diagnostic investigations:
92% Lab examinations; 38.5% GI contrast radiograph studies;
23% Abdominal US; 7% CT/MRI; 33.6% Upper GI endoscopy;
17% colonoscopy
Total costs: 744726 $
Cost/patient: 6104 $
JPGN 2010
Is it possible to save money maintaining a high diagnostic accuracy and cost/effective
treatment?
AIMS:
• To demonstrate that functional gastrointestinal disorders (FGIDs) can be diagnosed in a positive fashion and managed by family pediatricians (FPs);
• to assess the compliance of FPs with a predefined diagnostic/therapeutic protocol for managing FGIDs in order to evaluate efficacy of continuing medical education;
• to evaluate the success of reassurance by using a biopsychosocial model in comparison to drug treatment in an open-label, nonrandomized study.
Methods• Twenty-one FPs from Western Sicily
participated in the study• Seminar held by a senior
gastroenterologist to discuss Rome criteria and a validated questionnaire
• During a 3-month period FPs completed the questionnaire for all consecutive 1d-14yr old children who fulfilled Rome II criteria recording all children examined per day
Pediatric FGID in Rome II classification
Methods• Twenty-one FPs from Western Sicily
participated in the study• Seminar held by a senior
gastroenterologist to discuss Rome criteria and a validated questionnaire
• During a 3-month period FPs completed the questionnaire for all consecutive 1d-14yr old children who fulfilled Rome II criteria recording all children examined per day
• FPs were asked to follow the diagnostic/therapeutic protocol and in order to assess their compliance to record investigations and treatment prescribed
Definition of compliance with diagnostic and therapeutic protocols
Disorders Lab. Exam. Instrum. Exa. Drugs
Infant regurgitation
none none none
Functional Constipation
none none Macrogol for impaction and maintenance (or lactulose)
Functional dyspepsia
Amylase, lipase, aminotrasfer. Urinalysis, tTG for all
Acceptable abdomen US
Anti-H2 block. PPI, acceptable domperidone
Functional abdominal pain
Blood cell count ESR, stool exa. tTG for all
Acceptable abdomen US
No drug
Definition of compliance with diagnostic and therapeutic protocols
Disorders Lab. Exam. Instrum. Exa. Drugs
IBS Blood cell count ESR, stool exa. tTG for all, optional fecal calprotectine
In presence of red flags: colonoscopy with biopsy
Macrogol in presence of constipation
Red flags
• Epigastric or lower abdominal pain• Dysphagia • Arthritis or unexplained fever• Vomiting (once a week or more)• Gastrointestinal bleeding• Diarrhea and weight loss • Poor growth or pubertal delay • Perianal lesions • Family history of CD, IBD or peptic ulcer
Definition of compliance with diagnostic and therapeutic protocols
Disorders Lab. Exam. Instrum. Exa. Drugs
IBS Blood cell count ESR, stool exa. tTG for all, optional fecal calprotectine
In presence of red flags: colonoscopy with biopsy
Macrogol in presence of constipation
Functional diarrhea
Not mandatory Blood cell count ESR, stool exa. tTG for all
none No drug accepted but 1 empirical dose of tinidazole
Cyclic vomiting syndrome
Serum glucose, urea, aminotra. Amylase, lipase, metabolic panel
Ref. to Center for upper X-ray series and endoscopy, brain MRI, Ab. US
No drug, a trial with gastric acid inhib. or lorazepam allowed
Methods
• Each child who received a diagnosis of FGIDs was then re-evaluated through a standard sheet, by the same pediatrician after 1, 6 and 12 months to determine if there had been a change in diagnosis and to evaluate symptoms
• Gold standard for diagnosis was clinical status at 12-month follow-up
RESULTS
• A total of 9291 patients, aged birth to 14 years, were prospectively enrolled; 261 met Rome II criteria and were included in the study.
• In all cases but 4, diagnosis of FGIDs was confirmed at the end of follow-up (98.4%).
• Average compliance of FPs was 80%. • Among 56 patients treated only with the
explanation of symptom and reassurance, 52 (92.8%) have reported success, in comparison with 26 of 35 patients (74.3%) treated with drugs (odds ratio: 4.5 [95% confidence interval: 1.3–16]).
Author Dhroove et al.
Primavera et al.
Patient number 243 261
Laboratory examinations
92% 42%
GI contras radiograph studies
38.5% 1.9%
Abdominal US 23% 13.7%
CT/MRI 7% 0.7%
Upper GI endoscopy 33.6% 0.7%
Colonoscopy 17% 0.38%
Total costs 744726 $
Costs/patient 6104 $
Comparison of costs between two studies utilizing different diagnostic approach
Is it possible to replicate this study in other settings with higher prevalence
of organic diseases?
Disorders Lab. Exam. Instrum. Exa. Drugs
Infant regurgitation
none none none
Functional Constipation
none none Macrogol for impaction and maintenance (or lactulose
Functional dyspepsia
Amylase, lipase, aminotrasfer. Urinalysis, tTG H. pylori
Acceptable abdomen US
Anti-H2 block. PPI, acceptable domperidone
Functional abdominal pain
Blood cell count ESR, stool exa. tTG for all
Acceptable abdomen US
No drug
80 consecutive Chinese children ages 7 to 16 with FD
2 groups: without any alarm features
wth alarm features
All underwent upper endoscopy
Alarm features relevant to dyspepsia:-gastrointestinal blood loss- dysphagia -persistent vomiting, persistent right upper quadrant pain, -nocturnal pain-family history of PUD and involuntary weight loss
We believe that it may even be more cost-effective to perform screening tests of H pylori on male patients
The study does not suggest that a negative endoscopy improves the outcome of children with FGIDs
Is it possible to replicate this study in other settings with higher prevalence
of organic diseases?Disorders Lab. Exam. Instrum. Exa. Drugs
IBS Blood cell count ESR, stool exa. tTG for all, optional fecal calprotectine
In presence of red flags: colonoscopy with biopsy
Macrogol in presence of constipation
Functional diarrhea
Not mandatory Blood cell count ESR, stool exa. tTG for all
none No drug accepted but 1 empirical dose of tinidazole
Cyclic vomiting syndrome
Serum glucose, urea, aminotra. Amylase, lipase, metabolic panel
Ref. to Center for upper X-ray series and endoscopy, brain MRI, Ab. US
No drug, a trial with gastric acid inhib. or lorazepam allowed
Is it possible to replicate this study in other settings with higher prevalence
of organic diseases?
Is it possible or necessary to create a network with family pediatricians or general practioners?
OBJECTIVE—The objectives of this study were to (1) compare the cost of medical evaluation for children with functional abdominal pain or irritable bowel syndrome brought to a pediatric gastroenterologist versus children who remained in the care of their pediatrician
Is it possible to replicate this study in other settings with higher prevalence
of organic diseases?
Is it possible or necessary to create a network with family pediatricians or general practioners?
Is it possible to apply the protocol for out or in-patients in the hospital?